Cargando…
Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway
Background: Pulmonary fat embolism (PFE) is one of the important causes of acute lung injury (ALI), but its pathogenesis is unclear. In recent years, it has been found that the NLRP3 inflammasome is closely related to inflammatory response. However, there are no reports about the involvement of NLRP...
Autores principales: | Chen, Hong, Ding, Yongjie, Chen, Wei, Feng, Yun, Shi, Guochao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511253/ https://www.ncbi.nlm.nih.gov/pubmed/31123394 http://dx.doi.org/10.2147/DDDT.S196040 |
Ejemplares similares
-
Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
por: Yang, Jie, et al.
Publicado: (2022) -
Corticosteroids alleviate lipopolysaccharide‐induced inflammation and lung injury via inhibiting NLRP3‐inflammasome activation
por: Yang, Jia‐Wei, et al.
Publicado: (2020) -
Rutin alleviates ventilator-induced lung injury by inhibiting NLRP3 inflammasome activation
por: Chen, Shengsong, et al.
Publicado: (2023) -
Glibenclamide ameliorates the disrupted blood–brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome
por: Xu, Fulin, et al.
Publicado: (2019) -
Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro
por: Cai, Yang, et al.
Publicado: (2021)